PATRICK J KERINS
CIK 1235112 · last filed 2025-03-14
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$19.62B
Companies
37
Total Filings
137
Lifetime Open-Market Net
$40.37M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BZFDW | Director | 3,791,905 | $0.03 | $99.3K | -$938.8K | 13 | 2025-03-14 |
| SGMT | 10%+ Owner | 3,013,414 | $6.48 | $19.53M | $0 | 1 | 2024-01-31 |
| PhaseBio Pharmaceuticals Inc (PHAS) Delisted | 10%+ Owner | 4,857,525 | $0.07 | $340.5K | -$1.57M | 1 | 2022-10-26 |
| COUR | 10%+ Owner | 13,732,280 | $5.34 | $73.33M | $0 | 2 | 2021-05-21 |
| SPT | 10%+ Owner | 38,644 | $7.29 | $281.7K | $0 | 1 | 2020-11-17 |
| NET | 10%+ Owner | 4,244,177 | $228.48 | $969.71M | -$15.05M | 5 | 2020-11-13 |
| Mersana Therapeutics, Inc. (MRSN) Delisted | 10%+ Owner | 3,222 | $29.08 | $93.7K | $15.00M | 3 | 2020-09-16 |
| ARDX | 10%+ Owner | 8,097,725 | $5.69 | $46.08M | $31.67M | 7 | 2020-06-12 |
| TESARO, Inc. (TSRO) Delisted | 10%+ Owner | 0 | — | — | $46.68M | 6 | 2019-01-22 |
| Ra Pharmaceuticals, Inc. (RARX) Delisted | 10%+ Owner | 9,625,307 | — | — | $84.39M | 2 | 2018-12-14 |
| ASND | 10%+ Owner | 82,978,668 | $218.06 | $18.09B | $29.01M | 4 | 2018-09-10 |
| Surface Oncology, Inc. (SURF) Delisted | 10%+ Owner | 3,312,877 | $1.07 | $3.54M | $2.00M | 1 | 2018-04-23 |
| APPN | 10%+ Owner | 14,635 | $24.01 | $351.4K | -$66.07M | 4 | 2018-02-15 |
| SYBX | 10%+ Owner | 4,228,940 | $0.69 | $2.92M | $0 | 2 | 2018-01-26 |
| Care.com Inc (CRCM) Delisted | 10%+ Owner | 2,256,517 | — | — | $0 | 2 | 2017-11-08 |
| RYTM | 10%+ Owner | 4,359,956 | $88.38 | $385.33M | $9.35M | 1 | 2017-10-10 |
| MULESOFT, INC (MULE) Delisted | 10%+ Owner | 0 | — | — | $0 | 1 | 2017-03-22 |
| Roka BioScience, Inc. (ROKA) Delisted | 10%+ Owner | 3,216,810 | — | — | $4.60M | 3 | 2016-09-30 |
| Zosano Pharma Corp (ZSAN) Delisted | 10%+ Owner | 2,060,276 | $0.56 | $1.15M | -$59.2K | 1 | 2016-09-15 |
| OPOWER, INC. (OPWR) Delisted | 10%+ Owner | 0 | — | — | $0 | 1 | 2016-06-14 |
| CHANNELADVISOR CORP (ECOM) Delisted | Director | 35,853 | $23.09 | $827.8K | -$43.15M | 16 | 2016-03-01 |
| Epizyme, Inc. (EPZM) Delisted | 10%+ Owner | 407,151 | $1.47 | $598.5K | $24.00M | 4 | 2016-01-12 |
| Millennial Media Inc. (MM) Delisted | Director | 15,625 | — | — | -$21.48M | 6 | 2015-10-23 |
| Avalo Therapeutics, Inc. (CERC.U) Delisted | 10%+ Owner | 594,245 | — | — | $0 | 1 | 2015-10-20 |
| SYNLOGIC, INC. (MIRN) Delisted | 10%+ Owner | 2,114,375 | — | — | $6.00M | 1 | 2015-10-06 |
| BOX | 10%+ Owner | 0 | $25.39 | $0 | $0 | 1 | 2015-01-29 |
| CVENT INC (CVT) Delisted | 10%+ Owner | 3,995,115 | $8.52 | $34.04M | -$46.24M | 5 | 2014-11-28 |
| DERM | 10%+ Owner | 3,502,922 | $6.34 | $22.21M | $1.11M | 1 | 2014-10-08 |
| Viracta Therapeutics, Inc. (SNSS) Delisted | 10%+ Owner | 4,817,733 | $18.62 | $89.71M | -$283.8K | 4 | 2014-08-29 |
| Loxo Oncology, Inc. (LOXO) Delisted | 10%+ Owner | 1,789,420 | — | — | $3.00M | 1 | 2014-08-06 |
| GRPN | 10%+ Owner | 207,944 | $17.01 | $3.54M | $0 | 2 | 2013-09-17 |
| Clovis Oncology, Inc. (CLVS) Delisted | 10%+ Owner | 11,974 | $0.08 | $972 | $17.11M | 2 | 2013-06-05 |
| WDAY | 10%+ Owner | 1,730 | $130.80 | $226.3K | $0 | 2 | 2013-04-11 |
| FUSION-IO, INC. (FIO) Delisted | 10%+ Owner | 3,751 | — | — | -$43.38M | 14 | 2012-09-06 |
| HYPERION THERAPEUTICS INC (HPTX) Delisted | 10%+ Owner | 1,590,142 | — | — | $5.00M | 1 | 2012-08-02 |
| Echo Global Logistics, Inc. (ECHO) Delisted | 10%+ Owner | 2,020,316 | $48.24 | $97.46M | $0 | 1 | 2012-03-01 |
| ARYx Therapeutics, Inc. (ARYX) Delisted | 10%+ Owner | 0 | — | — | -$326.3K | 1 | 2011-03-14 |
Recent Filings · Page 4 of 14
137 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-08-01 | — | Mixed | +2,473,750 | $6.00M | |
| 2018-05-30 | ARDX | Grant (A) | +416,667 | $1.67M | EDGAR |
| 2018-05-09 | — | Mixed | — | $0 | |
| 2018-04-23 | Surface Oncology, Inc. (SURF) Delisted | Mixed | +3,312,877 | $2.00M | EDGAR |
| 2018-03-28 | ASND | Buy (P) | +6,571,164 | $12.59M | EDGAR |
| 2018-03-27 | — | Buy (P) | +2,123,892 | $5.73M | |
| 2018-03-23 | ASND | Buy (P) | +1,268,508 | $2.42M | EDGAR |
| 2018-03-06 | TESARO, Inc. (TSRO) Delisted | Buy (P) | +116,445 | $6.68M | EDGAR |
| 2018-02-15 | APPN | Mixed | +1,523 | $0 | EDGAR |
| 2018-01-26 | SYBX | Grant (A) | +410,000 | $4.00M | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.